The present invention generally relates to medical systems and apparatus and uses thereof for treating obesity and/or obesity-related diseases, and more specifically, relates to gastric banding systems that are remotely adjustable.
Adjustable gastric banding apparatus have provided an effective and substantially less invasive alternative to gastric bypass surgery and other conventional surgical weight loss procedures. Despite the positive outcomes of invasive weight loss procedures, such as gastric bypass surgery, it has been recognized that sustained weight loss can be achieved through a laparoscopically-placed gastric band, for example, the LAP-BAND® (Allergan, Inc., Irvine, Calif.) gastric band or the LAP-BAND AP® (Allergan, Inc., Irvine, Calif.) gastric band. Generally, gastric bands are placed about the cardia, or upper portion, of a patient's stomach forming a stoma that restricts the food's passage into a lower portion of the stomach. When the stoma is of an appropriate size that is restricted by a gastric band, the food is held in the upper portion of the stomach provides a feeling of satiety or fullness that discourages overeating. Unlike gastric bypass procedures, gastric band apparatus are reversible and require no permanent modification to the gastrointestinal tract.
Over time, a stoma created by a gastric band may need adjustment in order to maintain an appropriate size, which is neither too restrictive nor too passive. Accordingly, prior art gastric band systems provide a subcutaneous fluid access port connected to an expandable or inflatable portion of the gastric band. By adding fluid to or removing fluid from the inflatable portion by means of a hypodermic needle inserted into the access port, the effective size of the gastric band can be adjusted to provide a tighter or looser constriction. Naturally, it would be desirable to allow for non-invasive adjustment of gastric band constriction, for example, without the use of a hypodermic needle.
Birk, et al., U.S. Patent Pub. No. 2010-0010291, and Birk, et al., U.S. Ser. No. 12/705,245, which are commonly-assigned and co-pending with the present application, are incorporated herein in their entirety by this specific reference. Both of these applications disclose certain approaches to implantable pumping systems that may be relevant.
Jordan, et al., U.S. Patent Application Pub. Nos. 2008/0108862 and 2005/0104457, and Jordan, et al., U.S. Pat. No. 7,314,443 generally disclose an implantable device that utilizes a stepper motor to move a fluid utilized by the implantable device. However, these documents do not disclose a system for changing a diameter of a reservoir to inflate an inflatable portion of a gastric band.
Bachmann, U.S. Patent Application Pub. Nos. 2008/0002746 and 2005/0251182, Bachmann, et al., U.S. Patent Application Pub. Nos. 2005/0143766 and 2005/0143765, and Bachmann, U.S. Pat. No. 7,238,191 generally disclose a surgical ring that has an adjustable diameter. The diameter is adjusted using a screw thread that lengthens and shortens using a motor. However, these documents do not disclose a system for moving fluid from a reservoir to an inflatable portion of a gastric band.
Forsell, U.S. Patent Application Pub. No. 2001/0011543 and Forsell, U.S. Pat. No. 6,210,347, generally disclose an adjustable implantable device for restricting an opening in the body that food passes through. The implantable device is mechanically adjustable, but these documents do not disclose a system for adjusting the implantable device using fluid from a flexible reservoir.
Some mechanically adjustable implantable devices have a disadvantage of becoming inoperable if the adjustment mechanism fails. Furthermore, because the motor and the driving mechanisms are located near the restricting band itself, they are more subject to strain and damage from the implantation process. Therefore, it is desirable to develop a remotely adjustable gastric band where the motor is separated from the restricting band to reduce the strain from the implantation process such that the risk of damage during implantation is decreased.
Some attempts have been made to use piezoelectric pumps to drive fluid into an inflatable portion of a gastric band, but these pumps may not provide sufficient pumping power and/or may not satisfy other design specifications. Thus, it is desirable to develop a more efficient pumping mechanism.
Additionally, some attempts have been made to utilize a piezoelectrically driven bellows infuser to inflate an inflatable portion of a gastric band. However, these bellows infusers do not offer a reduced area against which pressure is applied after an amount of fluid has been pumped into the gastric band, which may result in higher power requirements and more energy dissipation. Therefore, it is desirable to develop a pumping mechanism that offers efficiencies as fluid is moved from a reservoir to a gastric band.
Further, some attempts have been made to measure pressure in various components of implantable systems. But these pressure measurements have generally been limited to measuring pressure in an injection port or in an organ such as the stomach. Therefore, it is desirable to develop a flexible reservoir with a means for measuring the pressure in the reservoir itself.
Thus, there continues to remain a need for more effective implantable pump systems for use with adjustable gastric bands, particularly such implantable pump systems with increased and more efficient pumping capability.
Generally described herein are remotely adjustable and powered gastric banding systems. The apparatus and systems described herein aid in facilitating obesity control and/or treating obesity-related diseases while being non-invasive once implanted.
In one embodiment, an implantable system comprises a housing that has a fluid inlet/outlet and a flexible reservoir positioned within the housing. The flexible reservoir is coupled to an inflatable portion of a gastric band via the fluid inlet/outlet. The flexible reservoir contains a fluid and has an expanded configuration and a contracted configuration.
A movable wall is slidably positioned around the flexible reservoir and forms a cylinder around the flexible reservoir. The movable wall has a diameter that may be changed by moving the ends of the movable wall. A driving mechanism, such as a flexible screw, is positioned around the movable wall, and is capable of changing the diameter of the movable wall to compress the flexible reservoir from the expanded configuration to the contracted configuration. When the flexible reservoir is compressed, a portion of the fluid in the flexible reservoir moves into the inflatable portion of the gastric band. The implantable system may also move the fluid out of the inflatable portion of the gastric band. A motor, coupled to the driving mechanism, may actuate the driving mechanism.
In an embodiment, the movable wall has a first end and a second end. The first end of the movable wall and the second end of the movable wall may be freely movable within the housing, or one of the two ends may be fixed to the housing. Furthermore, one end of the flexible screw may be attached to the housing.
Additionally, in an embodiment, the implantable system comprises a compressible structure positioned within the flexible reservoir. The compressible structure facilitates stabilizing boundaries of the flexible reservoir. The compressible structure may be selected from a group consisting of a tube, a sponge material, a synthetic material, a flexible material, and combinations thereof.
A sensing coil unit may be located near the sternum of a patient and may communicate with an external controller via radio frequency signals. The sensing coil unit may provide power and communications to the motor.
In various embodiments, a spring may be positioned around the movable wall to facilitate moving the movable wall. For example, the spring may be an elastic spring, a polymer spring, a stretchable spring, a coplanar spring, a sheath spring, an enclosing spring and/or combinations thereof. The spring may resist or assist the motor in expanding or contracting the movable wall.
The present invention generally provides remotely adjustable gastric banding systems, for example, for treatment of obesity and obesity related conditions, as well as systems for controlling inflation of gastric banding systems.
A remotely adjustable gastric band is a medical device which allows a healthcare worker to adjust a gastric band without utilizing hypodermic needles to connect to an implanted access port. An external, handheld controller can be used to send radio frequency signals for powering and communicating with the implanted device. The implanted device can fill or drain the gastric band as requested by the healthcare worker via the handheld controller. The handheld controller may be a remote device configured to produce a telemetric signal that controls the various components of the gastric banding system.
The filling and draining of the band is accomplished by a set of fluidic elements including pumps, valves, and sensors which monitor and/or move fluid between the gastric band and a reservoir. In accordance with various embodiments, different numbers, types, and orientations of the fluidic elements may be utilized to obtain the desired results. Any and/or all of these various components may be configured to be controlled by a remote transmitter, such as a handheld controller.
Turning now to
The reservoir unit 108 may move precisely metered volumes of fluid (e.g., saline, a drug, and/or combinations thereof) from the reservoir unit 108 through the flexible tubing 106 into the gastric band 105. The reservoir unit 108 may comprise a compressible reservoir, such as an elastic polymer, a balloon, a rubber container, a silicone container, a collapsible container, a non-elastomeric container, a bellows, and combinations thereof that are configured to contain the fluid. The motor housing 112 includes a motor configured to compress the compressible reservoir in order to fill or drain the gastric band 105.
Moving the fluid into the gastric band 105 causes inflation of at least one bladder, or inflatable member of the gastric band 105 and constricts around the cardia, or upper portion of the stomach, forming a stoma that restricts the passage of food into a lower portion of the stomach. This stoma can provide a patient with a sensation of satiety or fullness that discourages overeating. In contrast, moving the fluid out of at least one inflatable member of the gastric band 105 contracts the pressure around the cardia and allows a stoma to be at least partially released and regains the patient's hunger sensation.
The receiving coil 116 receives radio frequency signals from an external/remote handheld controller or transmitter to control operation of the system 100. Although “transmitter” may be used herein, it should be understood that the remote transmitter may also be a wireless receiver and/or transceiver operable to take readings from the system 100 to determine the amount of fluid entering and/or exiting the gastric band 105, and/or to send or receive other types of information associated with the gastric banding system 100.
In various embodiments, the remote transmitter provides access to system data and functions and is an external, handheld, reusable battery-powered device. The remote transmitter can be made of any rugged plastic material including, polypropylene, cyclicolephin co-polymer, nylon, and other compatible polymers and the like. Further, the remote transmitter has a user interface including at least one display and at least one user input. The remote transmitter permits a clinician or a patient to navigate through menu driven screens used for data entry, data collection, and control of the gastric banding system 100.
The remote transmitter is capable of communicating with the gastric banding system 100. “Capable of communicating” as used herein refers to the remote transmitter's ability to establish communications with the gastric banding system 100, yet still have the ability to break communication and the systems described herein still function. To establish communication, in one example embodiment, once the remote transmitter is initialized, a display shows a searching query for a nearby gastric banding system 100. As the remote transmitter is brought into range of the gastric banding system 100, the display shows the strength of the communication link. Once stable communications have been acquired, the display shows the serial number (or other unique patient data) of the system so a clinician can verify they have the appropriate patient records in hand. If the patient requires a tightening of the gastric band 105, the clinician can enter the amount of the desired volume increase. The remote transmitter can also display the current volume within the gastric band 105 and indicate the new volume as the gastric band 105 fills. The remote transmitter can also indicate desired and actual volumes during the gastric band 105 draining.
In accordance with various embodiments, the gastric banding system 100 allows for a remotely controlled adjustment without needles, non-invasively, by using the remote transmitter. A conventional access port 114 may be included as part of system 100 in order to provide alternate filling and draining capabilities, for example, to provide a fail-safe alternative in case the non-invasive functionality (e.g., motor, electronics, driving mechanism) becomes inoperative and/or ineffective. The access port 114 may be used to extract fluid from the system in case of an emergency or as a safety measure. However, non-invasively filling and draining the gastric band 105 using the reservoir unit 108 represents advantages over gastric banding systems that only use standard access ports. The access port 114 may further be used to prime the system with a desired amount of fluid upon implantation.
When compared to conventional gastric banding systems having standard access ports which exclusively require syringe access, the presently described systems and apparatus offer several benefits. First, for conventional access ports located under a thick layer of fatty tissue, which is generally the case as the devices are typically used to treat obesity, the access port can be difficult to locate. The present systems reduce or eliminate the need for port location as the use of the remote transmitter removes the necessity of adjustment using a syringe.
Secondly, accessing the access port in conventional systems, when there is ambiguity on its location, can cause damage by accidentally puncturing the tubing which connects the access port to the gastric band. This damage can require another surgery in order to repair the punctured tubing. Further, when a conventional access port cannot be located by palpation, x-ray imaging may be required to guide a needle into the access port. Such imaging practices put a patient at risk for x-ray radiation exposure. The present systems and apparatus remove the need for these unnecessary procedures and save the patient from x-ray radiation exposure. As described herein, the present systems and apparatus may be compatible with magnetic resonance imaging (MRI), which is much safer for a patient.
The fluids used within the systems include any fluid that is biocompatible and incompressible. The fluid has no adverse effect on the patient in the unlikely event that a leak emanates from the system. The fluid can simply be water or any biocompatible polymer oil such as castor oil. In an example embodiment, the fluid is saline, a drug, and/or combinations thereof. The tubing 106 connects certain components of the system 100 and comprises any biocompatible flexible tubing that does not degrade in vivo. The tubing 106 is configured to withstand hydraulic forces up to hundreds of psi without leakage.
According to various embodiments, and with reference to
Like a conventional access port, various components of the gastric banding system 200 may be sutured onto the rectus muscle sheath 202 or any other conveniently accessible muscle. For example, the access port 214 and/or the reservoir unit 208 may be sutured to the rectus muscle sheath 202. The rectus muscle sheath 202 provides a secure surface on which to attach the access port 214 under a layer of fat 203 that separates the patient's skin 204 from the muscle 202.
The receiving coil unit 216 may be located near the sternum of the patient 201, and a wire 217 may electronically couple the receiving coil unit 216 to the reservoir unit 208. In an embodiment as illustrated in
Turning to
A movable wall 320 wraps around the flexible pouch 310, with one end of the movable wall 320 overlapping the other end of the movable wall 320 such that the movable wall 320 forms a cylinder within which the flexible pouch 310 is located. Although “cylinder” is used to describe the shape of the movable wall 320 in the reservoir unit 308, it should be understood that the movable wall 320 may form any shape that is capable of compressing or expanding the flexible pouch 310. For example, the movable wall 320 may form an extended ellipse, oval, rectangle or other shape.
The movable wall 320 may have a constant height and/or thickness, or it may have a variable height and/or thickness. In an embodiment, the movable wall 320 may be disposed and/or covered in a material that reduces friction between the overlapping ends of the movable wall 320. For example, the movable wall 320 may be wrapped in a shrinkable Teflon (PTFE) tube.
As the ends of the movable wall 320 overlap to a greater extent, the diameter of the cylinder formed by the movable wall 320 decreases. Although “diameter” is used to describe a dimension of a cylinder, it should be understood that other geometric shapes of the movable wall 320 have other characteristic dimensions, and these dimensions may change as the movable wall 320 compresses or expands the flexible pouch 310.
The size and/or volume of the flexible pouch 310 decreases as the ends of the moveable wall 320 overlap to a greater degree. As the size of the flexible pouch 310 decreases, fluid is expelled from the flexible pouch 310 and is moved into the gastric band. On the other hand, as the diameter of the cylinder created by the movable wall 320 increases (i.e., the ends of the movable wall 320 overlap less), the size and/or volume of the flexible pouch 310 increases and fluid is drawn out of the gastric band into the flexible pouch 310.
The reservoir unit 308 comprises an inlet/outlet port 340 for allowing fluid to pass bidirectionally between the flexible pouch 310 and the access port. The reservoir unit further comprises an inlet/outlet port 342 for allowing fluid to pass bidirectionally between the flexible pouch 310 and the gastric band. The ports 340 and 342 are barbed to facilitate attachment to the flexible tubing and to allow bidirectional flow of the fluid into and out of the flexible pouch 310. The ports 340 and 342 may comprise one or more flow control devices for controlling movement of the fluid into or out of the flexible pouch 310. The flow control devices may be a valve, a tube, a regulator, and/or combinations thereof. Other embodiments may not include a flow control device.
In an embodiment, a motor 335 is disposed within the motor housing 312, and the motor 335 drives a driving mechanism 330, such as a rod, a string, a screw, or combinations thereof. In an embodiment, the driving mechanism 330 comprises a flexible screw, and in other embodiments, the driving mechanism 330 is partially a flexible screw and partially a string, a cord, a rod, a cable, or other flexible member. The motor 335 is coupled to the receiving coil unit via a wire 317. The motor 335 may be a piezoelectric motor, an electromagnetic motor, an AC motor, a DC motor, a stepper motor, and/or combinations thereof. Furthermore, the motor 335 may move the driving mechanism 330 by rotational and/or translational movement.
The driving mechanism 330 wraps around the movable wall 320 to facilitate increasing or decreasing the diameter of the cylinder formed by the movable wall 320. For example, as the driving mechanism 330 exits the housing 309 of the reservoir unit 308 through the motor 335 and into the motor housing 312, the diameter of the cylinder formed by the movable wall 320 decreases. Similarly, as the driving mechanism 330 enters the housing 309 of the reservoir unit 308, the diameter of the cylinder formed by the movable wall 320 increases.
The driving mechanism 330 may enter the housing 309 through the motor 335, and the motor may extend and withdraw the driving mechanism 330 into and out of the housing 309. The driving mechanism 330 wraps around the movable wall 320 to facilitate changing the diameter of the cylinder formed by the movable wall.
In one embodiment, as illustrated in
With one end of the driving mechanism 330 fixed to the housing 309, as the motor 335 draws the driving mechanism 330 out of the housing 309 and into the motor housing 312, the total length of the driving mechanism 330 in the housing 309 decreases, which causes the ends of the movable wall 320 to overlap to a greater degree. This greater overlap causes the size and/or volume of the flexible pouch 310 to decrease. In this configuration, where one end of the driving mechanism 330 is fixed to the housing 309, the motor 335 may be capable of exerting a greater force on the driving mechanism 330 than in the configuration where the driving mechanism 330 is attached directly to the movable wall 320. Thus, more friction between the overlapping ends of the movable wall 320 may be overcome where the driving mechanism 330 is fixed to the housing 309.
The movable wall 320 may move freely within the housing 309. In an embodiment, the movable wall 320 may move within tracks, guides, and/or paths in the housing 309. In another embodiment, guide posts or bearings may be utilized to guide the motion of the movable wall 320 within the housing 309.
As noted above, the size of the flexible pouch 310 changes as the diameter of the cylinder formed by the movable wall 320 changes. This change in diameter is accomplished by changing the length of the driving mechanism 330 within the housing 309. Thus, by knowing the length of the driving mechanism 330, either inside or outside the housing 309, the size and/or volume of the flexible pouch 310 may be determined, and accordingly, the amount of fluid within the gastric band may be determined.
In an embodiment, the external controller may display an estimated volume of fluid within the gastric band based on a distance traveled by the driving mechanism 330. The length of the driving mechanism 330 may be advantageously determined to provide a desired range of volumes within the gastric band and/or the flexible pouch 310. Furthermore, a sufficient amount of space within the motor housing 312 and the housing 309 of the reservoir unit 308 is designed to allow the driving mechanism 330 to have the desired range of motion.
In another embodiment, and with reference to
A second end 423 of the movable wall 420 is attached to the driving mechanism 430. As the driving mechanism 430 moves into and out of the housing 409, the second end 423 of the movable wall 420 moves with the driving mechanism 430 to cause the first end 422 to overlap to a greater or lesser degree with the second end 423. As the degree of overlap of the first and second ends 422 and 423 increases or decreases, the diameter of the cylinder formed by the movable wall 420 correspondingly decreases and increases, as discussed above.
Although the movable wall 420 may move freely within the housing 409, guides, rods, bearings, and combinations thereof may be utilized to guide the movement of the movable wall 420. For example, with reference to
In various embodiments as illustrated in
With reference to
With reference to
In various embodiments, the cylinder created by the movable wall 420 has a minimum diameter. For example, at a certain point, the driving mechanism 430 may have exited the housing 409 to the greatest extent possible. Because the minimum diameter may be greater than zero given the structure of the movable wall 420, some space may be left in the flexible pouch 410 when the minimum diameter is achieved. If fluid occupies this space, the reservoir unit 408 may be prone to leakage. However, in an embodiment, an internal structure 413 may be located within the flexible pouch 410 to occupy the space remaining when the minimum diameter is achieved. Thus, less fluid will occupy the remaining space, which reduces the chance of a fluid leak. Furthermore, various gages and other components, such as electronics or pressure sensors, may reside within the internal structure 413 to allow the gastric banding system to be more compact. In some embodiments, the flexible pouch 410 may be donut-shaped and/or crescent shaped to accommodate the internal structure 413.
A pressure sensor may be included in the internal structure 413, such that pressures from the gastric band and/or the flexible pouch 410 may be monitored. The pressure sensor provides a non-invasive method for verifying the functionality of the motor and/or the inflation status of the gastric band. The inclusion of a pressure sensor utilizes additional electronics, such as a driver circuit and two-way communications, with possible modifications to the power electronics of the receiving coil unit and modifications to the external controller for displaying pressure data.
In accordance with further embodiments, the motor 435 may provide different amounts of force as the motor 435 moves the driving mechanism 430 into or out of the housing 409. For example, in an embodiment, the motor 435 may provide less force when moving the driving mechanism 430 into the housing 409 (i.e., increasing the volume in the flexible pouch 410) than when moving the driving mechanism 430 out of the housing 409 (i.e., decreasing the volume in the flexible pouch 410 and moving the fluid to the gastric band). Thus, springs 445, such as coplanar springs, elastic bands, polymer springs, stretchable springs, sheath springs, enclosing springs, or other mechanisms, may be utilized to assist in decreasing the volume within the flexible pouch 410. If springs 445 are utilized, they may assist the motor in compressing the flexible pouch 410 in order to move fluid out of the flexible pouch 410. Further, when expanding the flexible pouch 410, the pressure within the gastric band, together with the power provided by the motor 435, may be sufficient to counteract the compressive force of the springs 445 to allow the flexible pouch 410 to expand.
Although the embodiments illustrated in
With reference to
In another embodiment, with reference to
As illustrated in
The movable wall may comprise different structures and materials according to various embodiments of the present invention. For example, Teflon material may be used for the movable wall, and/or Teflon tape may be utilized to cover the movable wall to reduce friction. In other embodiments, the movable wall may comprise an accordion-type structure. As illustrated in
In an embodiment, and with reference to
As illustrated in
“R1” and “R2” in
The pressures “P1” and “P2” represent the pressure exerted by the flexible reservoir against the movable wall 820 when the movable wall 820 is at R1 and R2. As the volume decreases in the flexible reservoir, the surface area of the movable wall 820 against which the pressure is applied decreases (i.e., a decreased diameter of the movable wall 820 leads to a reduced surface area). The resulting force necessary to counteract P1 and P2 and move the driving mechanism 830 is proportional to pressure times the area against which the pressure is applied.
The decrease in area of the movable wall 820 means that less force is utilized to move the driving mechanism 830 at R2 and P2 than at R1 and P1, if the pressure against the movable wall 820 were due solely to fluid in the reservoir. However, because the pressure within the inflatable portion of the gastric band increases with an increased volume, greater force is required to move additional fluid into the gastric band. Thus, the reduced force utilized at R2 and P2 helps to counteract the expected increase in pressure as volume in the gastric band increases. In contrast, where a syringe or plunger-type reservoir is used, the force required to fill the gastric band increases to a greater degree as the gastric band inflates, without any beneficial decrease in the force required to move the constant-area plunger.
Unless otherwise indicated, all numbers expressing quantities of ingredients, volumes of fluids, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained by the present invention. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective testing measurements.
The terms “a,” “an,” “the” and similar referents used in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. Recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member may be referred to and claimed individually or in any combination with other members of the group or other elements found herein. It is anticipated that one or more members of a group may be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.
Certain embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventor expects skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
Furthermore, certain references have been made to patents and printed publications throughout this specification. Each of the above-cited references and printed publications are individually incorporated herein by reference in their entirety.
Specific embodiments disclosed herein may be further limited in the claims using consisting of or and consisting essentially of language. When used in the claims, whether as filed or added per amendment, the transition term “consisting of” excludes any element, step, or ingredient not specified in the claims. The transition term “consisting essentially of” limits the scope of a claim to the specified materials or steps and those that do not materially affect the basic and novel characteristic(s). Embodiments of the invention so claimed are inherently or expressly described and enabled herein.
In closing, it is to be understood that the embodiments of the invention disclosed herein are illustrative of the principles of the present invention. Other modifications that may be employed are within the scope of the invention. Thus, by way of example, but not of limitation, alternative configurations of the present invention may be utilized in accordance with the teachings herein. Accordingly, the present invention is not limited to that precisely as shown and described.
Number | Name | Date | Kind |
---|---|---|---|
1174814 | Brennan et al. | Mar 1916 | A |
1830947 | Klingel | Nov 1931 | A |
1999683 | Borresen | Apr 1935 | A |
2163048 | McKee | Jun 1939 | A |
2339138 | Black | Jan 1944 | A |
2405667 | Ottesen | Aug 1946 | A |
2438231 | Schultz et al. | Mar 1948 | A |
2635907 | Heimbuch | Apr 1953 | A |
2714469 | Carlson | Aug 1955 | A |
2936980 | Rapata | May 1960 | A |
3059645 | Hasbrouck et al. | Oct 1962 | A |
3189961 | Heller | Jun 1965 | A |
3667081 | Burger | Jun 1972 | A |
3840018 | Heifetz | Oct 1974 | A |
3955834 | Ahlrot | May 1976 | A |
4053176 | Hilbush | Oct 1977 | A |
4118805 | Reimels | Oct 1978 | A |
4133315 | Berman et al. | Jan 1979 | A |
4157713 | Clarey | Jun 1979 | A |
4176412 | Peterson | Dec 1979 | A |
4236521 | Lauterjung | Dec 1980 | A |
4271827 | Angelchik | Jun 1981 | A |
4299012 | Oetiker | Nov 1981 | A |
4340083 | Cummins | Jul 1982 | A |
4399809 | Baro et al. | Aug 1983 | A |
4406656 | Hattler et al. | Sep 1983 | A |
4408597 | Tenney, Jr. et al. | Oct 1983 | A |
4417567 | Trick | Nov 1983 | A |
4424208 | Wallace et al. | Jan 1984 | A |
4442153 | Meltsch | Apr 1984 | A |
4450375 | Siegal | May 1984 | A |
4485805 | Foster, Jr. | Dec 1984 | A |
4492004 | Oetiker | Jan 1985 | A |
4551862 | Haber | Nov 1985 | A |
4558699 | Bashour | Dec 1985 | A |
4559699 | Owen et al. | Dec 1985 | A |
4582640 | Smestad et al. | Apr 1986 | A |
4582865 | Balazs et al. | Apr 1986 | A |
4592339 | Kuzmak et al. | Jun 1986 | A |
4592355 | Antebi | Jun 1986 | A |
4601713 | Fuqua | Jul 1986 | A |
4667672 | Romanowski | May 1987 | A |
4671351 | Rappe | Jun 1987 | A |
4693695 | Cheng | Sep 1987 | A |
4694827 | Weiner et al. | Sep 1987 | A |
4696288 | Kuzmak et al. | Sep 1987 | A |
4708140 | Baron | Nov 1987 | A |
4716154 | Malson et al. | Dec 1987 | A |
4753086 | Schmidt | Jun 1988 | A |
4760837 | Petit | Aug 1988 | A |
4803075 | Wallace et al. | Feb 1989 | A |
4881939 | Newman | Nov 1989 | A |
4883467 | Franetzki et al. | Nov 1989 | A |
4886787 | De Belder et al. | Dec 1989 | A |
4896787 | Delamour et al. | Jan 1990 | A |
4915690 | Cone et al. | Apr 1990 | A |
4925446 | Garay et al. | May 1990 | A |
4944487 | Holtermann | Jul 1990 | A |
4944659 | Labbe et al. | Jul 1990 | A |
4958791 | Nakamura | Sep 1990 | A |
4969899 | Cox, Jr. | Nov 1990 | A |
4994019 | Fernandez et al. | Feb 1991 | A |
5041094 | Perego et al. | Aug 1991 | A |
5045060 | Melsky et al. | Sep 1991 | A |
5074868 | Kuzmak | Dec 1991 | A |
5084061 | Gau et al. | Jan 1992 | A |
5089019 | Grandjean | Feb 1992 | A |
5091171 | Yu et al. | Feb 1992 | A |
5116652 | Alzner | May 1992 | A |
5120313 | Elftman | Jun 1992 | A |
5143724 | Leshchiner et al. | Sep 1992 | A |
5152770 | Bengmark et al. | Oct 1992 | A |
5160338 | Vincent | Nov 1992 | A |
5188609 | Bayless et al. | Feb 1993 | A |
5224494 | Enhorning | Jul 1993 | A |
5226429 | Kuzmak | Jul 1993 | A |
5246456 | Wilkinson | Sep 1993 | A |
5246698 | Leshchiner et al. | Sep 1993 | A |
5259399 | Brown | Nov 1993 | A |
5326349 | Baraff | Jul 1994 | A |
5343894 | Frisch et al. | Sep 1994 | A |
5356883 | Kuo et al. | Oct 1994 | A |
5360445 | Goldowsky | Nov 1994 | A |
5391156 | Hildwein et al. | Feb 1995 | A |
5399351 | Leshchiner et al. | Mar 1995 | A |
5449363 | Brust et al. | Sep 1995 | A |
5449368 | Kuzmak | Sep 1995 | A |
5458568 | Racchini et al. | Oct 1995 | A |
5496312 | Klicek | Mar 1996 | A |
5509888 | Miller | Apr 1996 | A |
5531716 | Luzio et al. | Jul 1996 | A |
5535752 | Halperin et al. | Jul 1996 | A |
5554113 | Novak et al. | Sep 1996 | A |
5562714 | Grevious | Oct 1996 | A |
5601604 | Vincent | Feb 1997 | A |
5607418 | Arzbaecher | Mar 1997 | A |
5633001 | Agerup | May 1997 | A |
5653718 | Yoon | Aug 1997 | A |
5658298 | Vincent et al. | Aug 1997 | A |
5676162 | Larson, Jr. et al. | Oct 1997 | A |
5695504 | Gifford, III et al. | Dec 1997 | A |
5704893 | Timm | Jan 1998 | A |
5713911 | Racenet et al. | Feb 1998 | A |
5733257 | Sternby | Mar 1998 | A |
5748200 | Funahashi | May 1998 | A |
5759015 | Van Lintel et al. | Jun 1998 | A |
5766232 | Grevious et al. | Jun 1998 | A |
5769877 | Barreras, Sr. | Jun 1998 | A |
5785295 | Tsai | Jul 1998 | A |
5807311 | Palestrant | Sep 1998 | A |
5817113 | Gifford, III et al. | Oct 1998 | A |
5827529 | Ono et al. | Oct 1998 | A |
5833698 | Hinchliffe et al. | Nov 1998 | A |
5861014 | Familoni | Jan 1999 | A |
RE36176 | Kuzmak | Mar 1999 | E |
5886042 | Yu et al. | Mar 1999 | A |
5904697 | Gifford, III et al. | May 1999 | A |
5910149 | Kuzmak | Jun 1999 | A |
5928195 | Malamud et al. | Jul 1999 | A |
5938669 | Klaiber et al. | Aug 1999 | A |
5944696 | Bayless et al. | Aug 1999 | A |
5944751 | Laub | Aug 1999 | A |
5993473 | Chan et al. | Nov 1999 | A |
6013679 | Kuo et al. | Jan 2000 | A |
6024340 | Lazarus et al. | Feb 2000 | A |
6024704 | Meador et al. | Feb 2000 | A |
6042345 | Bishop et al. | Mar 2000 | A |
6048309 | Flom et al. | Apr 2000 | A |
6067991 | Forsell | May 2000 | A |
6074341 | Anderson et al. | Jun 2000 | A |
6074378 | Mouri et al. | Jun 2000 | A |
6083249 | Familoni | Jul 2000 | A |
6090131 | Daley | Jul 2000 | A |
6102922 | Jakobsson et al. | Aug 2000 | A |
6164933 | Tani et al. | Dec 2000 | A |
6171321 | Gifford, III et al. | Jan 2001 | B1 |
6193734 | Bolduc et al. | Feb 2001 | B1 |
6203523 | Haller et al. | Mar 2001 | B1 |
6210345 | Van Brunt | Apr 2001 | B1 |
6210347 | Forsell | Apr 2001 | B1 |
6221024 | Miesel | Apr 2001 | B1 |
6224857 | Romeo et al. | May 2001 | B1 |
6306088 | Krausman et al. | Oct 2001 | B1 |
6327503 | Familoni | Dec 2001 | B1 |
6371965 | Gifford, III et al. | Apr 2002 | B2 |
6372494 | Naughton et al. | Apr 2002 | B1 |
6383218 | Sourdile et al. | May 2002 | B1 |
6383219 | Telandro et al. | May 2002 | B1 |
6387105 | Gifford, III et al. | May 2002 | B1 |
6417750 | Sohn | Jul 2002 | B1 |
6418934 | Chin | Jul 2002 | B1 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6432040 | Meah | Aug 2002 | B1 |
6439539 | Powell | Aug 2002 | B1 |
6443957 | Addis | Sep 2002 | B1 |
6443965 | Gifford, III et al. | Sep 2002 | B1 |
6450173 | Forsell | Sep 2002 | B1 |
6450946 | Forsell | Sep 2002 | B1 |
6450987 | Kramer | Sep 2002 | B1 |
6451034 | Gifford, III et al. | Sep 2002 | B1 |
6453907 | Forsell | Sep 2002 | B1 |
6454699 | Forsell | Sep 2002 | B1 |
6454700 | Forsell | Sep 2002 | B1 |
6454701 | Forsell | Sep 2002 | B1 |
6454785 | De Hoyos Garza | Sep 2002 | B2 |
6457801 | Fish et al. | Oct 2002 | B1 |
6460543 | Forsell | Oct 2002 | B1 |
6461293 | Forsell | Oct 2002 | B1 |
6463935 | Forsell | Oct 2002 | B1 |
6464628 | Forsell | Oct 2002 | B1 |
6470892 | Forsell | Oct 2002 | B1 |
6474584 | Ekich | Nov 2002 | B2 |
6475136 | Forsell | Nov 2002 | B1 |
6485496 | Suyker et al. | Nov 2002 | B1 |
6491704 | Gifford, III et al. | Dec 2002 | B2 |
6491705 | Gifford, III et al. | Dec 2002 | B2 |
6511490 | Robert | Jan 2003 | B2 |
6517556 | Monassevitch | Feb 2003 | B1 |
6527701 | Sayet et al. | Mar 2003 | B1 |
6547801 | Dargent et al. | Apr 2003 | B1 |
6565582 | Gifford, III et al. | May 2003 | B2 |
6579301 | Bales et al. | Jun 2003 | B1 |
6601604 | Cooper | Aug 2003 | B1 |
6615084 | Cigaina | Sep 2003 | B1 |
6627620 | Nielsen | Sep 2003 | B1 |
6630486 | Royer | Oct 2003 | B1 |
6632239 | Snyder et al. | Oct 2003 | B2 |
6646628 | Shirochi et al. | Nov 2003 | B2 |
6676674 | Dudai | Jan 2004 | B1 |
6681135 | Davis et al. | Jan 2004 | B1 |
6685668 | Cho et al. | Feb 2004 | B1 |
6685963 | Taupin et al. | Feb 2004 | B1 |
6691047 | Fredericks | Feb 2004 | B1 |
6715731 | Post et al. | Apr 2004 | B1 |
6729600 | Mattes et al. | May 2004 | B2 |
6754527 | Stroebel et al. | Jun 2004 | B2 |
6767924 | Yu et al. | Jul 2004 | B2 |
6811136 | Eberhardt et al. | Nov 2004 | B2 |
6820651 | Seuret et al. | Nov 2004 | B2 |
6834201 | Gillies et al. | Dec 2004 | B2 |
6871090 | He et al. | Mar 2005 | B1 |
6889086 | Mass et al. | May 2005 | B2 |
6916326 | Benchetrit | Jul 2005 | B2 |
6921819 | Piron et al. | Jul 2005 | B2 |
6924273 | Pierce | Aug 2005 | B2 |
6940467 | Fischer et al. | Sep 2005 | B2 |
6966875 | Longobardi | Nov 2005 | B1 |
7017583 | Forsell | Mar 2006 | B2 |
7017883 | Bayer et al. | Mar 2006 | B2 |
7021147 | Subramanian et al. | Apr 2006 | B1 |
7037344 | Kagan et al. | May 2006 | B2 |
7040349 | Moler et al. | May 2006 | B2 |
7048519 | Fong et al. | May 2006 | B2 |
7054690 | Imran | May 2006 | B2 |
7058434 | Wang et al. | Jun 2006 | B2 |
7060080 | Bachmann | Jun 2006 | B2 |
7066486 | Lee | Jun 2006 | B2 |
7118526 | Egle | Oct 2006 | B2 |
7119062 | Alvis et al. | Oct 2006 | B1 |
7128750 | Stergiopulos | Oct 2006 | B1 |
7144400 | Byrum et al. | Dec 2006 | B2 |
7172607 | Hofle et al. | Feb 2007 | B2 |
7177693 | Starkebsum | Feb 2007 | B2 |
7191007 | Desai et al. | Mar 2007 | B2 |
7198250 | East | Apr 2007 | B2 |
7204821 | Clare et al. | Apr 2007 | B1 |
7206637 | Salo | Apr 2007 | B2 |
7223239 | Schulze et al. | May 2007 | B2 |
7238191 | Bachmann | Jul 2007 | B2 |
7240607 | Fish | Jul 2007 | B2 |
7255675 | Gertner et al. | Aug 2007 | B2 |
7263405 | Boveja et al. | Aug 2007 | B2 |
7282023 | Frering | Oct 2007 | B2 |
7284966 | Xu et al. | Oct 2007 | B2 |
7288064 | Boustani et al. | Oct 2007 | B2 |
7297103 | Jarsaillon et al. | Nov 2007 | B2 |
7299082 | Feldman et al. | Nov 2007 | B2 |
7310557 | Maschino et al. | Dec 2007 | B2 |
7311503 | Van Lintel et al. | Dec 2007 | B2 |
7311716 | Byrum | Dec 2007 | B2 |
7311717 | Egle | Dec 2007 | B2 |
7314443 | Jordan et al. | Jan 2008 | B2 |
7314636 | Caseres et al. | Jan 2008 | B2 |
7338433 | Coe | Mar 2008 | B2 |
7340306 | Barrett et al. | Mar 2008 | B2 |
7351198 | Byrum et al. | Apr 2008 | B2 |
7351240 | Hassler, Jr. et al. | Apr 2008 | B2 |
7353747 | Swayze et al. | Apr 2008 | B2 |
7364542 | Jambor et al. | Apr 2008 | B2 |
7366571 | Armstrong | Apr 2008 | B2 |
7367340 | Nelson et al. | May 2008 | B2 |
7367937 | Jambor et al. | May 2008 | B2 |
7374565 | Hassler, Jr. et al. | May 2008 | B2 |
7390294 | Hassler | Jun 2008 | B2 |
7396353 | Lorenzen et al. | Jul 2008 | B2 |
7416528 | Crawford et al. | Aug 2008 | B2 |
7457668 | Cancel et al. | Nov 2008 | B2 |
7481763 | Hassler et al. | Jan 2009 | B2 |
7500944 | Byrum et al. | Mar 2009 | B2 |
7502649 | Ben-Haim et al. | Mar 2009 | B2 |
7530943 | Lechner | May 2009 | B2 |
7594885 | Byrum | Sep 2009 | B2 |
7599743 | Hassler, Jr. et al. | Oct 2009 | B2 |
7599744 | Giordano et al. | Oct 2009 | B2 |
7601162 | Hassler, Jr. et al. | Oct 2009 | B2 |
7615001 | Jambor et al. | Nov 2009 | B2 |
7618365 | Jambor et al. | Nov 2009 | B2 |
7658196 | Ferreri et al. | Feb 2010 | B2 |
7670279 | Gertner | Mar 2010 | B2 |
7699770 | Hassler, Jr. et al. | Apr 2010 | B2 |
7712470 | Gertner | May 2010 | B2 |
7727141 | Hassler, Jr. et al. | Jun 2010 | B2 |
7741476 | Lebreton | Jun 2010 | B2 |
7758493 | Gingras | Jul 2010 | B2 |
7763039 | Ortiz et al. | Jul 2010 | B2 |
7766815 | Ortiz | Aug 2010 | B2 |
7771439 | Griffiths | Aug 2010 | B2 |
7775215 | Hassler, Jr. et al. | Aug 2010 | B2 |
7775966 | Dlugos et al. | Aug 2010 | B2 |
7775967 | Gertner | Aug 2010 | B2 |
7794386 | Brooks | Sep 2010 | B2 |
7811298 | Birk | Oct 2010 | B2 |
7824422 | Benchetrit | Nov 2010 | B2 |
7828813 | Mouton | Nov 2010 | B2 |
7832407 | Gertner | Nov 2010 | B2 |
7841978 | Gertner | Nov 2010 | B2 |
7844342 | Dlugos et al. | Nov 2010 | B2 |
7862502 | Pool et al. | Jan 2011 | B2 |
7879068 | Dlugos et al. | Feb 2011 | B2 |
7951067 | Byrum et al. | May 2011 | B2 |
20010011543 | Forsell | Aug 2001 | A1 |
20020072780 | Foley | Jun 2002 | A1 |
20020091395 | Gabbay | Jul 2002 | A1 |
20020095181 | Beyar | Jul 2002 | A1 |
20020098097 | Singh | Jul 2002 | A1 |
20020139208 | Yatskov | Oct 2002 | A1 |
20020183765 | Adams | Dec 2002 | A1 |
20020193679 | Malave et al. | Dec 2002 | A1 |
20020198548 | Robert | Dec 2002 | A1 |
20030014003 | Gertner | Jan 2003 | A1 |
20030019498 | Forsell | Jan 2003 | A1 |
20030045775 | Forsell | Mar 2003 | A1 |
20030045902 | Weadock | Mar 2003 | A1 |
20030055311 | Neukermans et al. | Mar 2003 | A1 |
20030060873 | Gertner et al. | Mar 2003 | A1 |
20030066536 | Forsell | Apr 2003 | A1 |
20030073880 | Polsky et al. | Apr 2003 | A1 |
20030093157 | Caseres et al. | May 2003 | A1 |
20030100910 | Gifford, III et al. | May 2003 | A1 |
20030120288 | Benchetrit | Jun 2003 | A1 |
20030148995 | Piron et al. | Aug 2003 | A1 |
20030158564 | Benchetrit | Aug 2003 | A1 |
20030158569 | Wazne | Aug 2003 | A1 |
20030181890 | Schulze et al. | Sep 2003 | A1 |
20030181917 | Gertner | Sep 2003 | A1 |
20030191433 | Prentiss | Oct 2003 | A1 |
20030208212 | Cigaina | Nov 2003 | A1 |
20040000843 | East | Jan 2004 | A1 |
20040044332 | Stergiopulos | Mar 2004 | A1 |
20040049209 | Benchetrit | Mar 2004 | A1 |
20040059393 | Policker et al. | Mar 2004 | A1 |
20040068847 | Belisle et al. | Apr 2004 | A1 |
20040106899 | McMichael et al. | Jun 2004 | A1 |
20040133219 | Forsell | Jul 2004 | A1 |
20040147816 | Policker et al. | Jul 2004 | A1 |
20040148034 | Kagan et al. | Jul 2004 | A1 |
20040153106 | Dudai | Aug 2004 | A1 |
20040162595 | Foley | Aug 2004 | A1 |
20040215159 | Forsell | Oct 2004 | A1 |
20040230137 | Mouton | Nov 2004 | A1 |
20040254536 | Conlon et al. | Dec 2004 | A1 |
20040254537 | Conlon et al. | Dec 2004 | A1 |
20040260319 | Egle | Dec 2004 | A1 |
20040267288 | Byrum et al. | Dec 2004 | A1 |
20040267291 | Byrum et al. | Dec 2004 | A1 |
20040267292 | Byrum et al. | Dec 2004 | A1 |
20040267293 | Byrum et al. | Dec 2004 | A1 |
20040267377 | Egle | Dec 2004 | A1 |
20050002984 | Byrum et al. | Jan 2005 | A1 |
20050038484 | Knudson et al. | Feb 2005 | A1 |
20050038498 | Dubrow et al. | Feb 2005 | A1 |
20050055039 | Burnett et al. | Mar 2005 | A1 |
20050070934 | Tanaka et al. | Mar 2005 | A1 |
20050070937 | Jambor et al. | Mar 2005 | A1 |
20050100779 | Gertner | May 2005 | A1 |
20050104457 | Jordan et al. | May 2005 | A1 |
20050119672 | Benchetrit | Jun 2005 | A1 |
20050119674 | Gingras | Jun 2005 | A1 |
20050131383 | Chen et al. | Jun 2005 | A1 |
20050131485 | Knudson et al. | Jun 2005 | A1 |
20050136122 | Sadozai et al. | Jun 2005 | A1 |
20050142152 | Leshchiner et al. | Jun 2005 | A1 |
20050143765 | Bachmann et al. | Jun 2005 | A1 |
20050143766 | Bachmann et al. | Jun 2005 | A1 |
20050154274 | Jarsaillon et al. | Jul 2005 | A1 |
20050171568 | Duffy | Aug 2005 | A1 |
20050183730 | Byrum | Aug 2005 | A1 |
20050192531 | Birk | Sep 2005 | A1 |
20050192601 | Demarais | Sep 2005 | A1 |
20050192614 | Binmoeller | Sep 2005 | A1 |
20050192629 | Saadat et al. | Sep 2005 | A1 |
20050216042 | Gertner | Sep 2005 | A1 |
20050226936 | Agerup | Oct 2005 | A1 |
20050228415 | Gertner | Oct 2005 | A1 |
20050228504 | Demarais | Oct 2005 | A1 |
20050240155 | Conlon | Oct 2005 | A1 |
20050240156 | Conlon | Oct 2005 | A1 |
20050240279 | Kagan et al. | Oct 2005 | A1 |
20050244288 | O'Neill | Nov 2005 | A1 |
20050250979 | Coe | Nov 2005 | A1 |
20050251181 | Bachmann | Nov 2005 | A1 |
20050251182 | Bachmann | Nov 2005 | A1 |
20050267406 | Hassler, Jr. | Dec 2005 | A1 |
20050267500 | Hassler, Jr. et al. | Dec 2005 | A1 |
20050267533 | Gertner | Dec 2005 | A1 |
20050271729 | Wang | Dec 2005 | A1 |
20050277899 | Conlon et al. | Dec 2005 | A1 |
20050283041 | Egle | Dec 2005 | A1 |
20050288739 | Hassler | Dec 2005 | A1 |
20050288740 | Hassler, Jr. et al. | Dec 2005 | A1 |
20060015138 | Gertner | Jan 2006 | A1 |
20060020298 | Camilleri et al. | Jan 2006 | A1 |
20060041183 | Massen et al. | Feb 2006 | A1 |
20060074439 | Garner et al. | Apr 2006 | A1 |
20060074473 | Gertner | Apr 2006 | A1 |
20060089571 | Gertner | Apr 2006 | A1 |
20060122147 | Wohlrab | Jun 2006 | A1 |
20060142700 | Sobelman et al. | Jun 2006 | A1 |
20060142790 | Gertner | Jun 2006 | A1 |
20060161139 | Levine et al. | Jul 2006 | A1 |
20060161186 | Hassler et al. | Jul 2006 | A1 |
20060167531 | Gertner et al. | Jul 2006 | A1 |
20060173238 | Starkebaum | Aug 2006 | A1 |
20060173424 | Conlon | Aug 2006 | A1 |
20060178555 | Bortolotti | Aug 2006 | A1 |
20060183967 | Lechner | Aug 2006 | A1 |
20060189887 | Hassler, Jr. et al. | Aug 2006 | A1 |
20060189888 | Hassler, Jr. et al. | Aug 2006 | A1 |
20060189889 | Gertner | Aug 2006 | A1 |
20060194758 | Lebreton | Aug 2006 | A1 |
20060195139 | Gertner | Aug 2006 | A1 |
20060197412 | Rasmussen | Sep 2006 | A1 |
20060199997 | Hassler, Jr. et al. | Sep 2006 | A1 |
20060211912 | Dlugos et al. | Sep 2006 | A1 |
20060211913 | Dlugos et al. | Sep 2006 | A1 |
20060211914 | Hassler, Jr. et al. | Sep 2006 | A1 |
20060212051 | Snyder et al. | Sep 2006 | A1 |
20060212053 | Gertner | Sep 2006 | A1 |
20060235448 | Roslin et al. | Oct 2006 | A1 |
20060246137 | Hermitte et al. | Nov 2006 | A1 |
20060247721 | Maschino et al. | Nov 2006 | A1 |
20060247722 | Maschino et al. | Nov 2006 | A1 |
20060247724 | Gerber et al. | Nov 2006 | A1 |
20060252982 | Hassler, Jr. et al. | Nov 2006 | A1 |
20060252983 | Lembo et al. | Nov 2006 | A1 |
20060257488 | Hubbard | Nov 2006 | A1 |
20060264699 | Gertner | Nov 2006 | A1 |
20060276812 | Hill et al. | Dec 2006 | A1 |
20060293627 | Byrum et al. | Dec 2006 | A1 |
20070015954 | Dlugos | Jan 2007 | A1 |
20070015955 | Tsonton | Jan 2007 | A1 |
20070015956 | Crawford et al. | Jan 2007 | A1 |
20070016231 | Jambor et al. | Jan 2007 | A1 |
20070016262 | Gross et al. | Jan 2007 | A1 |
20070027356 | Ortiz | Feb 2007 | A1 |
20070027358 | Gertner et al. | Feb 2007 | A1 |
20070044655 | Fish | Mar 2007 | A1 |
20070077292 | Pinsky | Apr 2007 | A1 |
20070078476 | Hull, Sr. et al. | Apr 2007 | A1 |
20070125826 | Shelton | Jun 2007 | A1 |
20070156013 | Birk | Jul 2007 | A1 |
20070167672 | Dlugos et al. | Jul 2007 | A1 |
20070167982 | Gertner et al. | Jul 2007 | A1 |
20070173685 | Jambor et al. | Jul 2007 | A1 |
20070173888 | Gertner et al. | Jul 2007 | A1 |
20070179335 | Gertner et al. | Aug 2007 | A1 |
20070185373 | Tsonton | Aug 2007 | A1 |
20070185462 | Byrum | Aug 2007 | A1 |
20070213836 | Paganon | Sep 2007 | A1 |
20070218083 | Brooks | Sep 2007 | A1 |
20070232848 | Forsell | Oct 2007 | A1 |
20070232849 | Gertner | Oct 2007 | A1 |
20070233170 | Gertner | Oct 2007 | A1 |
20070235083 | Dlugos | Oct 2007 | A1 |
20070243227 | Gertner | Oct 2007 | A1 |
20070250085 | Bachmann et al. | Oct 2007 | A1 |
20070250086 | Wiley et al. | Oct 2007 | A1 |
20070255335 | Herbert et al. | Nov 2007 | A1 |
20070255336 | Herbert et al. | Nov 2007 | A1 |
20070265598 | Karasik | Nov 2007 | A1 |
20070265645 | Birk et al. | Nov 2007 | A1 |
20070265646 | McCoy et al. | Nov 2007 | A1 |
20070293716 | Baker et al. | Dec 2007 | A1 |
20070298005 | Thibault | Dec 2007 | A1 |
20080009680 | Hassler, Jr. | Jan 2008 | A1 |
20080015406 | Dlugos et al. | Jan 2008 | A1 |
20080015501 | Gertner | Jan 2008 | A1 |
20080027269 | Gertner | Jan 2008 | A1 |
20080027469 | Bachmann | Jan 2008 | A1 |
20080071306 | Gertner | Mar 2008 | A1 |
20080097496 | Chang et al. | Apr 2008 | A1 |
20080108862 | Jordan et al. | May 2008 | A1 |
20080147002 | Gertner | Jun 2008 | A1 |
20080161717 | Gertner | Jul 2008 | A1 |
20080161875 | Stone | Jul 2008 | A1 |
20080166028 | Turek et al. | Jul 2008 | A1 |
20080167647 | Gertner | Jul 2008 | A1 |
20080167648 | Gertner | Jul 2008 | A1 |
20080172072 | Pool et al. | Jul 2008 | A1 |
20080188766 | Gertner | Aug 2008 | A1 |
20080195092 | Kim et al. | Aug 2008 | A1 |
20080208240 | Paz | Aug 2008 | A1 |
20080221598 | Dlugos et al. | Sep 2008 | A1 |
20080243071 | Quijano et al. | Oct 2008 | A1 |
20080249806 | Dlugos | Oct 2008 | A1 |
20080250340 | Dlugos et al. | Oct 2008 | A1 |
20080250341 | Dlugos et al. | Oct 2008 | A1 |
20080255403 | Voegele et al. | Oct 2008 | A1 |
20080255414 | Voegele et al. | Oct 2008 | A1 |
20080255425 | Voegele et al. | Oct 2008 | A1 |
20080255459 | Voegele et al. | Oct 2008 | A1 |
20080255537 | Voegele et al. | Oct 2008 | A1 |
20080275294 | Gertner | Nov 2008 | A1 |
20080275295 | Gertner | Nov 2008 | A1 |
20080275484 | Gertner | Nov 2008 | A1 |
20080281347 | Gertner | Nov 2008 | A1 |
20080287969 | Tsonton et al. | Nov 2008 | A1 |
20080287974 | Widenhouse et al. | Nov 2008 | A1 |
20080287976 | Weaner et al. | Nov 2008 | A1 |
20080300618 | Gertner | Dec 2008 | A1 |
20080319435 | Rioux et al. | Dec 2008 | A1 |
20090054914 | Lechner | Feb 2009 | A1 |
20090062825 | Pool et al. | Mar 2009 | A1 |
20090062826 | Steffen | Mar 2009 | A1 |
20090082793 | Birk | Mar 2009 | A1 |
20090118572 | Lechner | May 2009 | A1 |
20090149874 | Ortiz et al. | Jun 2009 | A1 |
20090157106 | Marcotte et al. | Jun 2009 | A1 |
20090157107 | Kierath et al. | Jun 2009 | A1 |
20090157113 | Marcotte et al. | Jun 2009 | A1 |
20090171375 | Coe et al. | Jul 2009 | A1 |
20090171378 | Coe et al. | Jul 2009 | A1 |
20090171379 | Coe et al. | Jul 2009 | A1 |
20090187202 | Ortiz et al. | Jul 2009 | A1 |
20090192404 | Ortiz et al. | Jul 2009 | A1 |
20090192415 | Ortiz et al. | Jul 2009 | A1 |
20090192533 | Dlugos, Jr. et al. | Jul 2009 | A1 |
20090192534 | Ortiz et al. | Jul 2009 | A1 |
20090192541 | Ortiz et al. | Jul 2009 | A1 |
20090198261 | Schweikert | Aug 2009 | A1 |
20090202387 | Dlugos, Jr. et al. | Aug 2009 | A1 |
20090204131 | Ortiz et al. | Aug 2009 | A1 |
20090204132 | Ortiz et al. | Aug 2009 | A1 |
20090204141 | Dlugos, Jr. et al. | Aug 2009 | A1 |
20090204179 | Dlugos, Jr. et al. | Aug 2009 | A1 |
20090209995 | Byrum et al. | Aug 2009 | A1 |
20090216255 | Coe et al. | Aug 2009 | A1 |
20090220176 | Fusco | Sep 2009 | A1 |
20090222031 | Axelsson | Sep 2009 | A1 |
20090222065 | Dlugos, Jr. et al. | Sep 2009 | A1 |
20090228063 | Dlugos, Jr. et al. | Sep 2009 | A1 |
20090228072 | Coe et al. | Sep 2009 | A1 |
20090270904 | Birk et al. | Oct 2009 | A1 |
20090306462 | Lechner | Dec 2009 | A1 |
20090312785 | Stone et al. | Dec 2009 | A1 |
20100010291 | Birk et al. | Jan 2010 | A1 |
20100049224 | Vargas | Feb 2010 | A1 |
20100087843 | Bertolote et al. | Apr 2010 | A1 |
20100099945 | Birk et al. | Apr 2010 | A1 |
20100100079 | Berkcan | Apr 2010 | A1 |
20100145378 | Gertner | Jun 2010 | A1 |
20100152532 | Marcotte | Jun 2010 | A1 |
20100168508 | Gertner | Jul 2010 | A1 |
20100185049 | Birk et al. | Jul 2010 | A1 |
20100191265 | Lau et al. | Jul 2010 | A1 |
20100191271 | Lau et al. | Jul 2010 | A1 |
20100204647 | Gertner | Aug 2010 | A1 |
20100204723 | Gertner | Aug 2010 | A1 |
20100217071 | Ricol | Aug 2010 | A1 |
20100226988 | Lebreton | Sep 2010 | A1 |
20100228080 | Tavori et al. | Sep 2010 | A1 |
20100234682 | Gertner | Sep 2010 | A1 |
20100249803 | Griffiths | Sep 2010 | A1 |
20100280310 | Raven | Nov 2010 | A1 |
20100305397 | Birk et al. | Dec 2010 | A1 |
20100312046 | Lau et al. | Dec 2010 | A1 |
20100312147 | Gertner | Dec 2010 | A1 |
20100324358 | Birk et al. | Dec 2010 | A1 |
20100324359 | Birk | Dec 2010 | A1 |
20110201874 | Birk et al. | Aug 2011 | A1 |
Number | Date | Country |
---|---|---|
949965 | Jun 1974 | CA |
1250382 | Apr 2000 | CN |
1367670 | Sep 2002 | CN |
4225524 | Feb 1994 | DE |
10020688 | Dec 2000 | DE |
0119596 | Sep 1984 | EP |
0230747 | Aug 1987 | EP |
0416250 | Mar 1991 | EP |
0611561 | Aug 1994 | EP |
0695558 | Feb 1996 | EP |
0876808 | Nov 1998 | EP |
1036545 | Sep 2000 | EP |
1072282 | Jan 2001 | EP |
1105073 | Jun 2001 | EP |
1396242 | Mar 2004 | EP |
1396243 | Mar 2004 | EP |
1491167 | Dec 2004 | EP |
1491168 | Dec 2004 | EP |
1529502 | May 2005 | EP |
1547549 | Jun 2005 | EP |
1574189 | Sep 2005 | EP |
1600183 | Nov 2005 | EP |
1602346 | Dec 2005 | EP |
1704833 | Sep 2006 | EP |
1719480 | Nov 2006 | EP |
1754890 | Nov 2006 | EP |
1736123 | Dec 2006 | EP |
1736195 | Dec 2006 | EP |
1736202 | Dec 2006 | EP |
1743605 | Jan 2007 | EP |
1829504 | Sep 2007 | EP |
1829505 | Sep 2007 | EP |
1829506 | Sep 2007 | EP |
1967168 | Sep 2008 | EP |
1992315 | Nov 2008 | EP |
2074970 | Jul 2009 | EP |
2074971 | Jul 2009 | EP |
2074972 | Jul 2009 | EP |
2087862 | Aug 2009 | EP |
2095796 | Sep 2009 | EP |
2095798 | Sep 2009 | EP |
2191796 | Jun 2010 | EP |
1566202 | May 1969 | FR |
2688693 | Sep 1993 | FR |
2769491 | Apr 1999 | FR |
2783153 | Mar 2000 | FR |
2797181 | Feb 2001 | FR |
2799118 | Apr 2001 | FR |
2823663 | Oct 2002 | FR |
2855744 | Dec 2004 | FR |
2921822 | Apr 2009 | FR |
1174814 | Dec 1969 | GB |
2090747 | Jul 1982 | GB |
57-171676 | Oct 1982 | JP |
1-67309 | Apr 1989 | JP |
2-019147 | Jan 1990 | JP |
2-132104 | Nov 1990 | JP |
3-105702 | Nov 1991 | JP |
11-244395 | Sep 1999 | JP |
2003-526410 | Sep 2003 | JP |
2005-131380 | May 2005 | JP |
2005-334658 | Dec 2005 | JP |
8503144 | Dec 1986 | SE |
WO 8600079 | Jan 1986 | WO |
WO 8600912 | Feb 1986 | WO |
WO 8911701 | Nov 1989 | WO |
WO 9000369 | Jan 1990 | WO |
WO 9220349 | Nov 1992 | WO |
WO 9402517 | Feb 1994 | WO |
WO 9633751 | Jan 1996 | WO |
WO 9835639 | Aug 1998 | WO |
WO 9835640 | Aug 1998 | WO |
WO 0000108 | Jan 2000 | WO |
WO 0001428 | Jan 2000 | WO |
WO 0009047 | Feb 2000 | WO |
WO 0009048 | Feb 2000 | WO |
WO 0009049 | Feb 2000 | WO |
WO 0015158 | Mar 2000 | WO |
WO 0066196 | Nov 2000 | WO |
WO 0110359 | Feb 2001 | WO |
WO 0112078 | Feb 2001 | WO |
WO 0141671 | Jun 2001 | WO |
WO 0147435 | Jul 2001 | WO |
WO 0147575 | Jul 2001 | WO |
WO 0149245 | Jul 2001 | WO |
WO 0152777 | Jul 2001 | WO |
WO 0168007 | Sep 2001 | WO |
WO 0170131 | Sep 2001 | WO |
WO 0185071 | Nov 2001 | WO |
WO 0205753 | Jan 2002 | WO |
WO 0209792 | Feb 2002 | WO |
WO 0219953 | Mar 2002 | WO |
WO 0226317 | Apr 2002 | WO |
WO 02053093 | Jul 2002 | WO |
WO 02065948 | Aug 2002 | WO |
WO 02096326 | Dec 2002 | WO |
WO 03007782 | Jan 2003 | WO |
WO 03055420 | Jul 2003 | WO |
WO 03057092 | Jul 2003 | WO |
WO 03059215 | Jul 2003 | WO |
WO 03077191 | Sep 2003 | WO |
WO 03101352 | Dec 2003 | WO |
WO 03105732 | Dec 2003 | WO |
WO 2004014245 | Feb 2004 | WO |
WO 2004019671 | Mar 2004 | WO |
WO 2004108025 | Dec 2004 | WO |
WO 2004112563 | Dec 2004 | WO |
WO 2005007232 | Jan 2005 | WO |
WO 2005009305 | Feb 2005 | WO |
WO 2005067994 | May 2005 | WO |
WO 2005072195 | Aug 2005 | WO |
WO 2005087147 | Sep 2005 | WO |
WO 2005094447 | Oct 2005 | WO |
WO 2005112888 | Dec 2005 | WO |
WO 2006040647 | Apr 2006 | WO |
WO 2006049725 | May 2006 | WO |
WO 2006083885 | Aug 2006 | WO |
WO 2006108203 | Oct 2006 | WO |
WO 2007067206 | Jun 2007 | WO |
WO 2007081304 | Jul 2007 | WO |
WO 2007106727 | Sep 2007 | WO |
WO 2007114905 | Oct 2007 | WO |
WO 2007145638 | Dec 2007 | WO |
WO 2008063673 | May 2008 | WO |
WO 2008109300 | Sep 2008 | WO |
WO 2008134755 | Nov 2008 | WO |
WO 2009050709 | Apr 2009 | WO |
WO 2009132127 | Oct 2009 | WO |
WO 2009136126 | Nov 2009 | WO |
WO 2010042493 | Apr 2010 | WO |
Entry |
---|
Acuna-Goycolea et al.; “Mechanism of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Inhibition of Identified Green Fluorescent Protein-Expressing GABA Neurons in the Hypothalamic Neuroendocrine Acruate Nucleus”; The Journal of Neuroscience; V. 25(32); pp. 7406-7419; Aug. 10, 2005. |
Adrian et al.; “Mechanism of Pancreatic Polypeptide Release in Man.” The Lancet; pp. 161-163; Jan. 22, 1977. |
Anson; “Shape Memory Alloys—Medical Applications,” Source: Materials World, vol. 7, No. 12, pp. 745-747, Dec. 1999. |
Asakawa et al; “Antagonism of Ghrelin Receptor Reduces Food Intake and Body Weight Gain in Mice”; Gut.; V.52; pp. 947-952; 2003. |
Baggio et al. “Biology of Incretins: GLP-1 and GIP”; Gastroenrology; V. 132; pp. 2131-2157; 2007. |
Ballantyne; “Peptide YY(1-36) and Peptide YY(3-36): Part I. Distribution, Release, and Actions”; Obesity Surgery; V.16; pp. 651-658; 2006. |
Ballantyne; “Peptide YY(1-36) and Peptide YY(3-36): Part II. Changes after Gastrointestinal Surgery and Bariatric Surgery”; Obesity Surgery; V.16; pp. 795-803; 2006. |
Berne et al; “Physiology”; V. 5; pp. 55-57, 210, 428, 540, 554, 579, 584, 591; 2004. |
BioEnterics Lap-Band Adjustable Gastric Banding System, Inamed Health, pub., pp. 1-115; Aug. 28, 2003. |
Boulant et al.; “Cholecystokinin in Transient Lower Oesophageal Sphincter Relaxation Due to Gastric Distension in Humans”; Gut.; V. 40; pp. 575-581; 1997. |
Bradjewin et al.; “Dose Ranging Study of the Effects of Cholecystokinin in Healthy Volunteers”; J. Psychiatr. Neurosci.; V. 16 (2); pp. 91-95; 1991. |
Burdyga et al.; “Cholecystokinin Regulates Expression of Y2 Receptors in Vagal Afferent Neurons Serving the Stomach”; The Journal of Neuroscience; V. 28; No. 45; pp. 11583-11592; Nov. 5, 2008. |
Chaptini et al.; “Neuroendocrine Regulation of Food Intake”; Current Opinion in Gastroenterology; V. 24; pp. 223-229; 2008. |
Chaudhri; “Can Gut Hormones Control Appetite and Prevent Obesity?” Diabetes Care; V. 31; Supp 2; pp. S284-S289; Feb. 2008. |
Cohen et al.; “Oxyntomodulin Suppresses Appetite and Reduces Food Intake in Humans”; J. Clin. Endocrinol. Metab.; V. 88; No. 10; pp. 4696-4701; 2003. |
Corno et al.; “A new implantable device for telemetric control of pulmonary blood flow”; New ideas; received Apr. 24, 2004; received in revised form Jul. 12, 2002; 10 pages. |
Corno et al.; “FlowWatchTM in clipped and in clipped position”; Interact Cardio Vase Thorac Surg 2002; 1:46-49; Copyright @ 2002 The European Association for Cardio-thoracic Surgery; 1 page. |
Cummings et al.; “Plasma Ghrelin Levels After Diet-Induced Weight Loss or Gastric Bypass Surgery”; N. Engl J. Med; V. 346, No. 21; pp. 1623-1630; May 23, 2002. |
Cummings; “Gastrointestinal Regulation of Foot Intake”; The Food Journal of Clinical Investigation; V. 117, N. 1; pp. 13-23; Jan. 2007. |
Dakin et al.; “Oxyntomodulin Inhibits Food Intake in the Rat”; Endocrinology; V. 142; No. 10; pp. 4244-4250; 2001. |
Dakin et al.; “Peripheral Oxyntomodulin Reduces Food Intake and Body Weight gain in Rats”; Endocrinology; V. 145; No. 6; pp. 2687-2695; Jun. 2004. |
Davison; “Activation of Vagal-Gastric Mechanoreceptors by Cholecystokinin”; Proc. West. Pharmocol. Soc.; V. 29; pp. 363-366; 1986. |
De Waele et al.; “Endoscopic Volume Adjustment of Intragastric Balloons for Intolerance”; Obesity Surgery; V. 11; pp. 223-224;2001. |
De Waele et al.; “Intragastric Balloons for Preoperative Weight Reduction”; Obesity Surgery; V. 58; pp. 58-60; 2001. |
Desai et al.; “Molecular Weight of Heparin Using 13C Nuclear Magnetic Resonance Spectroscopy” Journal of Pharmaceutical Science, V. 84, I 2; 1995, Abstract only. |
Doldi et al.; “Intragastric Balloon: Another Option for Treatment of Obesity and Morbid Obesity”; Hepato-Gastroenterology; V. 51, N. 55; pp. 294-307; Jan.-Feb. 2004. |
Doldi et al.; “Treatment of Morbid Obesity with Intragastric Balloon in Association with Diet”; Obesity Surgery; V. 10, pp. 583-587; 2000. |
Doldi et al; “Intragastric Balloon in Obese Patients”; Obesity Surgery; V. 10, 578-581; 2000. |
Ekblad et al.; “Distribution of Pancreatic Peptide and Peptide-YY”; Peptides; V. 23; pp. 251-261; 2002. |
El Khoury et al.; “Variation in Postprandial Ghrelin Status Following Ingestion of High-Carbohydrate, High Fat, and High Protein Meals in Males”; Ann Nutr Metab; V. 50; pp. 260-269; 2006. |
Galloro et al; “Preliminary Endoscopic Technical Report of an New Silicone Intragastric Balloon in the Treatment of Morbid Obesity”; Obesity Surgery; V. 9, pp. 68-71; 1999. |
GinShiCel MH Hydroxy Propyl Methyl Cellulose, Web Page http://www.ginshicel.cn/MHPC.html, Nov. 12, 2008. |
Girard; “The incretins: From the concept to their use in the treatment of type 2 diabetes. Part A: Incretins: Concept and physiological functions”; Diabetes and Metabolism; V. 34; pp. 550-559; 2008. |
Greenough et al.; “Untangling the Effects of Hunger, Anxiety, and Nausea on Energy Intake During Intravenous Cholecystokinin Octapeptide (CCK-8) Infusion”; Physiology & Behavior; V. 65, No. 2; pp. 303-310; 1998. |
Grise et al.; “Peptide YY Inhibits Growth of Human Breast Cancer in Vitro and in Vivo”; Journal of Surgical Research; V. 82; pp. 151-155; 1999. |
Grundy; “Signaling the State of the Digestive Tract”; Autonomic Neuroscience: Basic and Clinical; V. 125; pp. 76-80; 2006. |
Grundy; “Vagal Control of Gastrointestinal Function”; Bailliere's Clinical Gastroenterology; V. 2; No. 1; pp. 23-43; 1988. |
Hallden et al. “Evidence for a Role of the Gut Hormone PYY in the Regulation of Intestinal Fatty Acid Binding Protein Transcripts in Differentiated Subpopulations of Intestinal Epithelial Cell Hybrids”; Journal of Biological Chemistry; V. 272 (19); pp. 125916-126000; 1997. |
Hameed et al.; “Gut hormones and appetite control.” Oral Diseases; V. 15; pp. 18-26; 2009. |
Hassan et al.; “Effects of Adjuvants to Local Anesthetics on Their Duration III Experimental Studies of Hyaluronic Acid” Abstract Pub Med [Acta Anesthesiol Scand.; 29 (4): 384-8], 1 page; May 1985. |
Hodson et al.; “Management of Obesity with the New Intragastric Balloon”; Obesity Surgery;.V. 11, pp. 327-329, 2001. |
Holzer; “Gastrointestinal Afferents as Targets of Novel Drugs for the Treatment of Functional Bowel Disorders and Visceral Pain”; European Journal of Pharmacology; V. 429; pp. 177-193; 2001. |
Houpt; “Gastrointestinal Factors in Hunger and Satiety.” Neuroscience and Behavioral Reviews; V. 6; pp. 145-164; 1982. |
Iverson et al.; “Recent Advances in Microscale Pumping Technologies: A Review and Evaluation”; Microfluid Nanofluid; vol. 5; pp. 145-174; Feb. 19, 2008. |
Jones; “Molecular, pharmacological, and clinical aspects of liraglutide, a oncedaily human GLP-1 analogue”; Molecular and Cellular Endocrinology; V. 297; pp. 137-140; 2009. |
Kerem et al.; “Exogenous Ghrelin Enhances Endocrine and Exocrine Regeneration in Pancreatectomized Rats”; J Gastrointest Surg.; V.13; pp. 775-783, 2009. |
Kesty et al.; “Hormone-based therapies in the regulation of fuel metabolism and body weight”; Expert Opin. Biol. Ther.; V. 8; No. 11; pp. 1733-1747; 2008. |
Kissileff et al.; “Peptides that Regulate Food Intake: Cholecystokinin and Stomach Distension Combine to Reduce Food Intake in Humans”; Am. J. Physiol. Regul. Integr. Comp. Physiol; V. 285; pp. 992-998; 2003. |
Kojima et al.; “A role for pancreatic polypeptide in feeding and body weight regulation.” Peptides; V. 28; pp. 459-463; 2007. |
Kulicke et al. “Visco-Elastic Propeerties of Sodium Hyaluronate Solutions,” American Institute of Physics; pp. 585-587; 2008. |
Lap-Band AP System Adjustable Gastric Banding System With OmniformTM Design: Directions for Use (DFU); Allergan, 16 pages; 2009. |
Le Roux et al.; “Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters”; Ann. Surg; V. 243; No. 1; pp. 108-114; Jan. 2006. |
Liu et al.; “Adjuvant Hormonal Treatment With Peptide YY or Its Analog Decreases Human Pancreatic Carcinoma Growth”; The American Journal of Surgery; V. 171; pp. 192-196; Jan. 1996. |
Mathus-Vliegen et al. “Intragastric Balloons for Morbid Obesity: Results, Patient Tolerance and Balloon Life Span”; Br. J. Surg.; V. 77, No. 7, pp. 76-79; Jan. 1990. |
Mathus-Vliegen et al. “Treating Morbid and Supermorbid Obesity” International Journal of Gastroenterology; V. 5, No. 1, pp. 9-12; 2000. |
Medeiros et al.; “Processing and metabolism of Peptide-YY: Pivotal roles of Dipeptidase-IV, Aminopeptidase-P, and Endopeptidase-24.11”; Endocrinology; V. 134, No. 5; pp. 2088-2094; 1994. |
Naslund et al. “Pranidal subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects”; British Journal of Nutrition; V. 91; pp. 439-446; 2004. |
Potier et al.; “Protein, amino acids, and the control of food intake”; Current Opinion in Clinical Nutrition and Metabolic Care; V. 12; pp. 54-58; 2009. |
Qian et al.; “Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117”; International Journal of Pharmaceutics; V. 366; pp. 218-220; 2008. |
Rang et al.; “Pharmacology”; V. 5; pp. 203, 397, 402, 524; 2004. |
Raybould et al.; “Integration of Postprandial Gastrointestinal Tract: Role of CCK and Sensory Pathways”; Annals of New York Academy of Science; pp. 143-156; 1994. |
Renshaw et al. “Peptide YY: A Potential Therapy for Obesity”; Current Drug Targets; V. 6; pp. 171-179; 2005. |
Sannino et al.; “Crosslinking of Cellulose Derivatives and Hyaluronic Acid with Water-Soluble Carbodiimide” Polymer 46; pp. 11206-11212; 2005. |
Shechter et al.; “Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice”; FEBS Letters; V. 579; pp. 2439-2444; 2005. |
Silver et al.; “Physical Properties of Hyaluronic Acid and Hydroxypropylmethylcellulose in Solution: Evaluation of Coating Abillity” Journal of Applied Biomaterials, V. 5; pp. 89-98, 1994. |
Small et al.; “Gut hormones and the control of appetite”; Trends in Endocrinology and Metabolism; V. 15. No. 6; pp. 259-263; Aug. 2004. |
Stanley et al.; “Gastrointestinal Satiety Signals III. Glucagon-like Peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide”; Am. J. Physiol Gastrointest Liver Physiol; V. 286; pp. 693-697; 2004. |
Tezel; “The Science of Hyaluronic Acid Dermal Fillers,” Journal of Cosmetic and Laser Therapy (2008) 10: pp. 35-42. |
Tolhurst et al.; “Nutritional regulation of glucagon-like peptide1 secretion”; J. Physiol.; V. 587, No. 1; pp. 27-32; 2009. |
Totte et al.; “Weight Reduction by Means of Intragastric Device: Experience with the Bioenterics Intragastric Balloon”; Obesity Surgery; V. 11, pp. 519-523; 2001. |
Tough et al.; “Y4 Receptors Mediate the Inhibitory Responses of Pancreatic Polypeptide in Human and Mouse Colon Mucosa”; The Journal of Pharmacology and Experimental Therapeutics; V. 319, No. 1; pp. 20-30; 2006. |
Tseng et al; “Peptide YY and cancer: Current findings and potential clinical applications”; Peptides; V. 23; pp. 389-395; 2002. |
Valassi et al.; “Neuroendocrine control of food intake”; Nut. Metab. & Cariovasc. Disease; V. 18; pp. 158-168; 2008. |
Van Der Lely et al.; “Biological, Physiological, Pathophysiological Aspects of Ghrelin”; Endocrine Reviews; V. 25, No. 3; pp. 426-457; 2004. |
Verdich et al. “A Meta-Analysis of the Effect of Glucagon-Like-Peptide-1 (7-36) Amide on ad Libitum Energy Intake in Humans”; J. Clin. Endocrinal. Metab. V. 86; pp. 4382-4389; Sep. 2001. |
Wahlen et al.; “The BioEnterics Intragastric Balloon (BIB): How to Use It”; Obesity Surgery; V. 11; pp. 524-527; 2001. |
Wang et al.; “Plasma Ghrelin Modulation in Gastric Band Operation and Sleeve Gastrectomy”; Obes. Surg.; pp. 357-362; 2008. |
Weiner et al.; “Preparation of Extremely Obese Patients for Laparoscopic Gastric Banding by Gastric Balloon Therapy”; Obesity Surgery; V. 9, pp. 261-264, 1999. |
Wynne et al.; “Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects: A Double-Blind Randomized, Controlled Trial”; Diabetes; V. 54; pp. 2390-2395; 2005. |
Yuzuriha et al.; “Gastrointestinal Hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development”; FASEB J.; V. 21; pp. 2108-2112; 2007. |
Brown et al; “Symmetrical Pouch Dilation After Laparoscopic Adjustable Gastric Banding: Incidence and Management”; Obesity Surgery; V. 18, pp. 1104-1108; 2008. |
Ceelen et al.; “Surgical Treatment of Severe Obesity With a Low-Pressure Adjustable Gastric Band: Experimental Data and Clinical Results in 625 Patients”; Annals of Surgery; V. 237, No. 1; pp. 10-16; 2003. |
Dixon et al.; “Pregnancy After Lap-Band Surgery: Management of the Band to Achieve Healthy Weight Outcomes”; Obesity Surgery; V. 11, pp. 59-65; 2001. |
Neary et al.; “Peptide YY(3-36) and Glucagon-Like Peptide-1(7-36) Inhibit Food Intake Additively”; Endocrinology; V.146; pp. 5120-5127; 2005. |
Padidela et al.; “Elevated basal and post-feed glucagon-like petide 1 (GLP-1) concentrations in the neonatel period”; European Journal of Endocrinology; v. 160; pp. 53-58; 2009. |
Shi et al.; “Sexually Dimorphic Responses to Fat Loss After Caloric Restriction or Surgical Lipectomy”; Am. J. Physiol. Endocrinol. Metab.; V. 293; E316-E326; 2007. |
Xanthakos et al.; “Bariatric Surgery for Extreme Adolescent Obesity: Indications, Outcomes, and Physiologic Effects on the Gut-Brain Axis”; Pathophysiology; V. 15; pp. 135-146; 2008. |
U.S. Appl. No. 12/705,245, filed Feb. 12, 2010, Birk, et al. |
Number | Date | Country | |
---|---|---|---|
20110306824 A1 | Dec 2011 | US |